Castlight Health Inc (NYSE:CSLT) EVP Neeraj Gupta sold 8,738 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $3.61, for a total value of $31,544.18. Following the sale, the executive vice president now directly owns 275,255 shares of the company’s stock, valued at $993,670.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Neeraj Gupta also recently made the following trade(s):
- On Wednesday, May 1st, Neeraj Gupta sold 2,500 shares of Castlight Health stock. The shares were sold at an average price of $3.75, for a total value of $9,375.00.
- On Monday, April 1st, Neeraj Gupta sold 2,500 shares of Castlight Health stock. The shares were sold at an average price of $3.78, for a total value of $9,450.00.
- On Friday, March 1st, Neeraj Gupta sold 12,500 shares of Castlight Health stock. The shares were sold at an average price of $3.80, for a total value of $47,500.00.
- On Wednesday, February 20th, Neeraj Gupta sold 14,417 shares of Castlight Health stock. The shares were sold at an average price of $3.11, for a total value of $44,836.87.
Shares of CSLT traded down $0.13 on Friday, reaching $3.42. 716,300 shares of the company’s stock traded hands, compared to its average volume of 450,608. The company has a current ratio of 1.87, a quick ratio of 1.87 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $525.45 million, a price-to-earnings ratio of -21.38 and a beta of 1.56. Castlight Health Inc has a 52-week low of $1.86 and a 52-week high of $5.95.
Castlight Health (NYSE:CSLT) last released its earnings results on Thursday, February 28th. The software maker reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.03) by $0.02. Castlight Health had a negative return on equity of 11.47% and a negative net margin of 23.04%. The business had revenue of $42.10 million during the quarter, compared to the consensus estimate of $40.61 million. As a group, equities research analysts predict that Castlight Health Inc will post -0.12 earnings per share for the current year.
Large investors have recently added to or reduced their stakes in the business. Amalgamated Bank purchased a new stake in Castlight Health in the fourth quarter worth $25,000. Parametric Portfolio Associates LLC purchased a new stake in Castlight Health in the first quarter worth $63,000. BNP Paribas Arbitrage SA increased its position in Castlight Health by 847.1% in the first quarter. BNP Paribas Arbitrage SA now owns 18,174 shares of the software maker’s stock worth $68,000 after buying an additional 16,255 shares during the last quarter. Virtu Financial LLC purchased a new stake in Castlight Health in the first quarter worth $77,000. Finally, Two Sigma Investments LP purchased a new stake in Castlight Health in the fourth quarter worth $51,000. 49.30% of the stock is owned by institutional investors and hedge funds.
Separately, Zacks Investment Research downgraded Castlight Health from a “hold” rating to a “sell” rating in a research report on Tuesday, May 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $5.06.
About Castlight Health
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.
Read More: How to Invest in an Index Fund
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.